Education
About Us
Working with TipRanks
Follow Us
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
Dnth103
Chronic Inflammatory Demyelinating Polyneuropathy
Phase III
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Feb 18, 2025
―
Dnth103
Multifocal Motor Neuropathy
Phase II
Recruiting
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
Jul 31, 2024
―
Dnth103
Myasthenia Gravis, Generalized
Phase II
Active Not Recruiting
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
Dec 15, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Dianthus Therapeutics (DNTH) have in its pipeline
DNTH is currently developing the following drugs: Dnth103, Dnth103, Dnth103. These drug candidates are in various stages of clinical development as the company works toward FDA approval.